News | Absci

Home

All
Blog Posts
Press Releases

07.26.2021

Absci Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

07.22.2021

A Message from Absci’s CEO

07.21.2021

Absci Announces Pricing of Initial Public Offering

07.07.2021

Absci Strengthens Executive Leadership Team with Strategic Hires to Support Business Growth

06.30.2021

Absci Announces Filing of Registration Statement for Proposed Initial Public Offering

06.14.2021

AbSci Announces Acquisition of Target Discovery Company Totient

03.23.2021

AbSci Announces Completion of $125 Million Crossover Financing to Advance AI-Powered Synthetic Biology Drug Creation Platform

02.22.2021

AbSci Announces Strategic Investment by Merck Global Health Innovation Fund

02.03.2021

AbSci Enters Biologics Development Collaboration with Xyphos Biosciences, an Astellas Company

1 2 Next »

Find out more